{"id":"healive-havrix","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or soreness"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Myalgia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Healive is an inactivated hepatitis A vaccine developed by Sinovac, while Havrix is the brand name for GSK's hepatitis A vaccine. This combination formulation stimulates the immune system to produce antibodies against both hepatitis A and B viruses, providing protective immunity against infection with these pathogens. The vaccines contain inactivated (killed) virus particles or recombinant antigens that trigger humoral and cellular immune responses without causing disease.","oneSentence":"Healive+Havrix is a combination vaccine that provides immunization against hepatitis A and hepatitis B through inactivated viral antigens.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:36:53.965Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of hepatitis A infection"},{"name":"Prevention of hepatitis B infection"}]},"trialDetails":[{"nctId":"NCT00534885","phase":"PHASE4","title":"Safety, Immunogenicity, and Immune Persistence Study of an Inactivated Hepatitis A Vaccine","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2006-03","conditions":"Hepatitis A","enrollment":400},{"nctId":"NCT01252680","phase":"PHASE4","title":"Immunogenicity and Interchangeability of Two Inactivated Hepatitis A Vaccines","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2010-04","conditions":"Hepatitis A","enrollment":303}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Hepatitis A vaccine"],"phase":"marketed","status":"active","brandName":"Healive+Havrix","genericName":"Healive+Havrix","companyName":"Sinovac Biotech Co., Ltd","companyId":"sinovac-biotech-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"Healive+Havrix is a combination vaccine that provides immunization against hepatitis A and hepatitis B through inactivated viral antigens. Used for Prevention of hepatitis A infection, Prevention of hepatitis B infection.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}